NCT01698684

Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction

A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men With Erectile Dysfunction

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 440 (actual)
• Sponsor: VIVUS LLC · Industry
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objectives of this study are to examine the therapeutic effects of two doses of avanafil after dosing in men with erectile dysfunction

Conditions

• Erectile Dysfunction

Interventions

Type	Name	Description
DRUG	Placebo	One dose 15 minutes before attempting intercourse
DRUG	Avanafil 100 mg	One dose 15 minutes before attempting intercourse
DRUG	Avanafil 200 mg	One dose 15 minutes before attempting intercourse

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2012-10-03
• Last updated: 2014-10-27
• Results posted: 2014-10-27

Locations

3 sites across 1 country: United States